Cryopreservation Equipment Market Report 2025

The cryopreservation equipment market size has grown rapidly in recent years. It will grow from $9.52 billion in 2024 to $11.01 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to increased demand for regenerative medicine, growth in stem cell research, expansion of biobanking, advancements in fertility preservation, rising healthcare expenditure, government initiatives for stem cell preservation, technological advancements in cryopreservation equipment, increased awareness of personalized medicine, growth in organ transplantation procedures, and development of cryogen-free preservation systems.

The cryopreservation equipment market size is expected to see rapid growth in the next few years. It will grow to $19.55 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. Contributing factors to this future growth include rising adoption of biobanking practices, expanding research in stem cell therapies, technological improvements in cryopreservation technologies, greater awareness of personalized medical treatments, and strong governmental support for biological preservation efforts. Additionally, increasing global healthcare expenditure, rising organ transplantation needs, and innovations in cryogen-free systems are anticipated to further drive the market.

The increasing demand for regenerative medicines is expected to propel the growth of the cryopreservation equipment market going forward. Regenerative medicines refer to therapies that repair, replace, or regenerate damaged tissues or organs to restore normal function. The rise in demand for regenerative medicines is driven by their potential to restore damaged tissues, offering long-term solutions and reducing the need for repeated treatments. Cryopreservation equipment supports regenerative medicines by enabling the long-term storage of cells, tissues, and other biological materials without compromising their viability or therapeutic potential. For instance, in January 2025, according to the catapult, a UK-based biotechnology company, clinical trials, including gene therapies, cell therapies, and tissue-engineered products, in 2024 accounted for 9.5% of global trials and nearly 50% of all European trials. These clinical trials support the expansion of regenerative medicine. Therefore, the increasing demand for regenerative medicines is driving the cryopreservation equipment market.

Major companies operating in the cryopreservation equipment market are focusing on developing innovative solutions, such as one-stop hubs for cell and gene therapy, to streamline the preservation, storage, and transport of biological materials, enhance process efficiency, and support the rapid commercialization of advanced therapies. One-stop hubs for cell and gene therapy refer to integrated facilities that provide comprehensive services from processing and cryopreservation to storage and distribution within a single location. For instance, in October 2024, Cryoport Inc., a US-based temperature-controlled supply chain solutions provider for life sciences, launched its IntegriCell cryopreservation services. The service is offered through Cryoport Systems at a newly opened, advanced facility on its Houston supply chain campus. This facility focuses on standardized cryopreservation of leukapheresis material. It integrates seamlessly with Cryoport’s global logistics platform to support cell therapy development and commercialization. The move strengthens Cryoport’s capabilities in biostorage and cell therapy logistics.

In April 2025, BioLife Solutions, a US-based biotechnology company, acquired PanTHERA CryoSolutions for an undisclosed amount. This acquisition strengthens BioLife’s position in the bio preservation sector by broadening its range of consumables and adding scientific depth to its leadership team. PanTHERA CryoSolutions Inc. is a Canada-based firm focused on producing cryopreservation products.

Major players in the cryopreservation equipment market are Thermo Fisher Scientific Inc., Linde LLC, Danaher Corporation, Merck KGaA, Avantor Inc., Beckman Coulter Inc., PHC Corporation, Chart Biomedical Co. Ltd., Hamilton Company, Azenta Life Sciences, Cryoport Systems Inc., Chemglass Life Sciences Inc., BioLife Solutions Inc., Charter Medicals, Planer PLC, CellBios Healthcare and Lifesciences Pvt. Ltd., Antech Group Inc., Cryologic Pty. Ltd., Blue-chip Ltd., and Haimen United Laboratory Equipment Development Co. Ltd.

North America was the largest region in the cryopreservation equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cryopreservation equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cryopreservation equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cryopreservation equipment market consists of sales of freezers, incubators, cryogenic storage tanks, sample preparation systems, and accessories used for freezing and storing biological materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cryopreservation equipment market research report is one of a series of new reports that provides cryopreservation equipment market statistics, including the cryopreservation equipment industry global market size, regional shares, competitors with the cryopreservation equipment market share, detailed cryopreservation equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the cryopreservation equipment industry. This cryopreservation equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cryopreservation equipment encompasses specialized devices used to store biological specimens - such as cells, tissues, and organs - at extremely low temperatures, typically below -150°C. These instruments include cryogenic storage tanks, freezers, and other associated accessories that employ either liquid nitrogen or mechanical refrigeration systems to suspend biological activity. This preservation method ensures the long-term viability and function of samples, making them suitable for use in biobanking, regenerative medicine, and various research applications.

The primary categories of cryopreservation equipment consist of freezers, incubators, sample preparation systems, and complementary accessories. Freezers are designed to maintain ultra-low temperatures and include types such as ultra-low temperature (ULT) freezers, mechanical freezers, cryogenic freezers, liquid nitrogen freezers, and portable models. These tools are applied in preserving a variety of biological materials including cord blood stem cells, sperm, semen, testicular tissues, embryos, and oocytes. They are utilized by a range of end users, including stem cell banks, contract research organizations, pharmaceutical and biotechnology companies, academic and research institutions, and stem cell research laboratories.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.